Clinical Trial Update: A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating the pharmacokinetics, pharmacodynamics, safety, and tolerability of SB414 in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SB414 (SB414)

Snippet

Sponsor: Novan, Inc. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED